Brief: Roquefort Therapeutics Says Deadline For Lyramid Sale Extended To 31 August 2025
27/06/2025 07:14
June 27 (Reuters) - Roquefort Therapeutics PLC ROQ.L: ROQUEFORT THERAPTCS. - LYRAMID SPA EXTENSION ROQUEFORT THERAPEUTICS PLC - EXTENDS DEADLINE FOR LYRAMID SALE TO 31 AUGUST 2025 ROQUEFORT THERAPEUTICS PLC - PLEIADES EXPERIENCING FUNDRAISING DELAYS DUE TO RECENT GEOPOLITICAL EVENTS Source text: ID:nRSa6479Oa Further company coverage: ROQ.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coiled Therapeutics
See all newsRCS - Coiled Therapeutics - Investor Presentation via Engage Investor
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts